Abstract
Despite incredible advancement made in recent years, treatment of cancer still remains the most challenging task for the mankind. The new small molecule therapeutic drugs are more specific, exhibit better therapeutic efficacy and mostly contain scaffolds of β-lactam, sulfonamide, quinoline, quinazoline, quinoxaline, purine, pyrimidine, resorcinol, pyrazole/isoxazole, benzamide etc. The structure-activity relationships of different pharmacophores that have been reported to potently inhibit cell growth of human tumour cell lines are constantly being investigated. Development of products of natural origin can also prove effective without submitting to harmful radiation and chemotherapy treatments. Under these circumstances, the practicing organic chemists are greatly facing the challenge of designing new and leading anti-cancer drugs based on natural products and scaffolds of potent pharmacaophores. The review intends to cover new approach of anti-cancer drug design using natural and synthetic pharmacophores. The plausible synthetic routes to major drugs for oncology that were approved recently by Food and Drug Administration (FDA) are also discussed.
Keywords: Anti-cancer drug, phamacophoric scaffold, oncology, synthesis, natural & herbal product, hybrid drug, FDA-approved drug.
Current Organic Chemistry
Title:Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores
Volume: 19 Issue: 15
Author(s): Pinaki S. Bhadury and Jun Pang
Affiliation:
Keywords: Anti-cancer drug, phamacophoric scaffold, oncology, synthesis, natural & herbal product, hybrid drug, FDA-approved drug.
Abstract: Despite incredible advancement made in recent years, treatment of cancer still remains the most challenging task for the mankind. The new small molecule therapeutic drugs are more specific, exhibit better therapeutic efficacy and mostly contain scaffolds of β-lactam, sulfonamide, quinoline, quinazoline, quinoxaline, purine, pyrimidine, resorcinol, pyrazole/isoxazole, benzamide etc. The structure-activity relationships of different pharmacophores that have been reported to potently inhibit cell growth of human tumour cell lines are constantly being investigated. Development of products of natural origin can also prove effective without submitting to harmful radiation and chemotherapy treatments. Under these circumstances, the practicing organic chemists are greatly facing the challenge of designing new and leading anti-cancer drugs based on natural products and scaffolds of potent pharmacaophores. The review intends to cover new approach of anti-cancer drug design using natural and synthetic pharmacophores. The plausible synthetic routes to major drugs for oncology that were approved recently by Food and Drug Administration (FDA) are also discussed.
Export Options
About this article
Cite this article as:
S. Bhadury Pinaki and Pang Jun, Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores, Current Organic Chemistry 2015; 19 (15) . https://dx.doi.org/10.2174/1385272819666150525234749
DOI https://dx.doi.org/10.2174/1385272819666150525234749 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy
Current Medicinal Chemistry Functional Role of Glycosphingolipids in Cancer
Current Medicinal Chemistry From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
Current Medicinal Chemistry Expression Profiles and Bioinformatics Analysis of Full-length circRNA Isoforms in Gliomas
Current Bioinformatics Astrocytes as a 5-HT2B-Mediated SERT-Independent SSRI Target, Slowly Altering Depression-Associated Genes and Function
Current Signal Transduction Therapy Gallium in Cancer Treatment
Current Topics in Medicinal Chemistry The J-shaped Association Between Alcohol Consumption and Breast Cancer: A Case-Control Study
Current Nutrition & Food Science Targeting Tumor Lymphangiogenesis: An Update
Current Medicinal Chemistry Application of Efficient Nanoparticles for Early Diagnosis and Treatment of Cancer
Current Drug Metabolism Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets Involvement of Leukotriene Pathway in the Pathogenesis of Ischemia- Reperfusion Injury and Septic and Non-Septic Shock
Current Vascular Pharmacology Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19
Current Drug Targets Targeting IAPs as An Approach to Anti-Cancer Therapy
Current Topics in Medicinal Chemistry Nutritional Antioxidants and Adaptive Cell Responses: An Update
Current Molecular Medicine Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates
Anti-Cancer Agents in Medicinal Chemistry Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
Cardiovascular & Hematological Agents in Medicinal Chemistry Modulation of intracellular pH in human ovarian cancer.
Current Molecular Medicine A Review on the Development in the Field of NIDDM based Thiazolidinedione PPARγ Agonists
Mini-Reviews in Medicinal Chemistry Innovations and Opportunities to Improve Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
Current Medicinal Chemistry The Role for Oxidative Stress in Aberrant DNA Methylation in Alzheimer’s Disease
Current Alzheimer Research